Citadel Advisors
NTUS

Citadel Advisors’s Natus Medical Inc NTUS Stock Holding History

Citadel Advisors’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,800
Closed -$281K – 15133
2021
Q2 		$281K Buy
+10,800
New +$294K ﹤0.01% 11423
2020
Q3 		– Sell
-17,900
Closed -$391K – 11009
2020
Q2 		$391K Buy
17,900
+3,800
+27% +$87K ﹤0.01% 7475
2020
Q1 		$326K Buy
14,100
+7,400
+110% +$215K ﹤0.01% 7183
2019
Q4 		$221K Sell
6,700
-5,400
-45% -$173K ﹤0.01% 8040
2019
Q3 		$385K Sell
12,100
-4,800
-28% -$140K ﹤0.01% 7192
2019
Q2 		$434K Sell
16,900
-2,600
-13% -$66.3K ﹤0.01% 7040
2019
Q1 		$495K Buy
19,500
+4,200
+27% +$125K ﹤0.01% 6801
2018
Q4 		$521K Buy
15,300
+4,600
+43% +$150K ﹤0.01% 6333
2018
Q3 		$381K Sell
10,700
-600
-5% -$21.2K ﹤0.01% 7168
2018
Q2 		$390K Buy
11,300
+3,400
+43% +$119K ﹤0.01% 6776
2018
Q1 		$266K Sell
7,900
-4,200
-35% -$133K ﹤0.01% 6923
2017
Q4 		$462K Sell
12,100
-6,200
-34% -$248K ﹤0.01% 5775
2017
Q3 		$686K Buy
18,300
+10,100
+123% +$356K ﹤0.01% 4874
2017
Q2 		$306K Buy
+8,200
New +$296K ﹤0.01% 5877
2017
Q1 		– Sell
-6,000
Closed -$209K – 8226
2016
Q4 		$209K Buy
+6,000
New +$236K ﹤0.01% 6252
2016
Q1 		– Sell
-5,000
Closed -$240K – 8361
2015
Q4 		$240K Sell
5,000
-5,300
-51% -$245K ﹤0.01% 5547
2015
Q3 		$406K Buy
10,300
+700
+7% +$29.7K ﹤0.01% 5091
2015
Q2 		$409K Buy
9,600
+6,200
+182% +$247K ﹤0.01% 5284
2015
Q1 		$134K Sell
3,400
-3,300
-49% -$122K ﹤0.01% 6596
2014
Q4 		$241K Buy
6,700
+600
+10% +$20.2K ﹤0.01% 5748
2014
Q3 		$180K Buy
6,100
+5,600
+1,120% +$155K ﹤0.01% 5831
2014
Q2 		$13K Sell
500
-2,700
-84% -$66.8K ﹤0.01% 7498
2014
Q1 		$83K Buy
+3,200
New +$80.6K ﹤0.01% 6365

Other funds holding NTUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors's NTUS Position: Q2 2022 in Review

Citadel Advisors sold out of Natus Medical Inc (NTUS) in Q2 2022, closing a stake of 11,014 shares — an estimated $289K sold.

Citadel Advisors first reported a position in NTUS in Q2 2013 and held it in 33 quarters. The position peaked at $7.87M in Q2 2017. 186 funds tracked by Wall St. Rank hold NTUS as of Q2 2022.

  • Citadel Advisors reported no remaining Natus Medical Inc position as of Q2 2022 after selling out during the quarter.
  • Citadel Advisors sold 11,014 Natus Medical Inc shares in Q2 2022, an estimated $289K.
  • Citadel Advisors first reported a position in Natus Medical Inc in Q2 2013 and held it in 33 quarters.
  • Citadel Advisors's Natus Medical Inc position peaked at $7.87M in Q2 2017.
  • 186 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2022.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.